News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Cleveland Clinic

Advertisement

Articles by Cleveland Clinic

Cleveland Clinic

Cleveland Clinic Opens New Cancer Center in Abu Dhabi

ByCleveland Clinic
March 23rd 2023

The state-of-the-art facility represents the organization’s vision of global cancer care

Cleveland Clinic Selected for Participation in National Chemical Biology Consortium

Cleveland Clinic Selected for Participation in National Chemical Biology Consortium

ByCleveland Clinic
January 27th 2023
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Oncology Nursing News

    1

    FDA OKs Subcutaneous Amivantamab Across All NSCLC Indications

    2

    Maintenance Tucatinib/HP Improves PFS Post 2-Year Mark in HER2+ mBC

    3

    Mobile Health Intervention Ups QOL in AYA Breast Cancer Survivors

    4

    T-DXd/Pertuzumab Combo Earns FDA Approval in Advanced HER2+ Breast Cancer

    5

    1L Giredestrant Yields Improved IDFS vs ET in ER+/HER2– Breast Cancer

    • About Us
    • Editorial Board
    • Contact Us
    • CancerNetwork.com
    • CureToday.com
    • OncLive.com
    • TargetedOnc.com
    • Advertise
    • Privacy
    • Terms & Conditions
    • Do Not Sell My Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us